Open Access

Work of breathing, not dysoxia, as the cause of low central venous blood O2 saturation in sepsis

Critical Care201620:291

https://doi.org/10.1186/s13054-016-1476-1

Published: 19 September 2016

The review by Nguyen et al. [1] acknowledges the substantially lower baseline central venous oxygen saturation (ScvO2) values reported by Rivers et al. [2] (48.6 ± 11.2 %) when compared to those for ProCESS [3] (71 ± 13 %), ARISE [4] (72.7 ± 10.5 %) and ProMISe [5] (64 ± 20 %) trials. Assuming normality, the distribution of baseline ScvO2 values in the study by Rivers et al. differed from those of the other trials (Fig. 1; p < 0.0001 by t test). Nguyen et al. ascribed this difference to “earlier central venous catheter (CVC) placement, greater shock severity or imbalances between O2 delivery and O2 consumption before corrective interventions”.
Fig. 1

Gaussian distributions for baseline SCVO2 reported by Rivers et al [2], ProCESS [3], ARISE [4] and ProMISe trials [5]. Baseline SCVO2 was substantially lower in the Rivers et al trial when compared to each of the other trials (p < 0.0001)

One aspect of these trials that has been ignored up to now is the CVC position in the superior vena cava. According to accepted guidelines, the tip of the CVC should lie below the anterior first rib and above the right atrium, placing the tip of the CVC below the opening of the azygos vein, a vessel carrying venous blood from the intercostal muscles and portions of the diaphragm.

In the study by Rivers et al., 53.8 % of patients randomized to the early goal-directed therapy (EGDT) group required invasive mechanical ventilation during the first 6 h of treatment, a greater rate (p < 0.0001; Chi Square test) than those reported by ProCESS (26.4 %), ARISE (22.2 %), and ProMISe (19 %). Furthermore, the baseline respiratory rate for the EGDT cohort in Rivers et al. (31.8 ± 10.8 bpm) was greater (p < 0.001) than those reported by ProCESS (25.4 ± 7.0 bpm) and ARISE (24. ± 7.5 bpm). The baseline respiratory rate for patients in the ProMISe trial was not reported.

These data infer that patients in the study of Rivers et al. experienced considerable respiratory distress prior to the initiation of mechanical ventilation. This condition was likely associated with an increased work of breathing and the discharge of highly desaturated blood by the azygos vein into the superior vena cava, in close proximity to the fiber optic lumen of the catheter tip, precisely where ScvO2 was measured spectrophotometrically.

It is reasonable, therefore, to propose that the low ScvO2 values reported in the study of Rivers et al. reflected work by the muscles of respiration and not sepsis-associated systemic tissue dysoxia. In that instance, the ScvO2 increases observed during the first 6 h of treatment in the study by Rivers et al. may have been in response to unloading of respiratory muscles by mechanical ventilation and not to red blood cell transfusion or dobutamine infusion as proposed by their treatment algorithm.

Abbreviations

CVC: 

Central venous catheter

EGDT: 

early goal-directed therapy

ScvO2: 

Central venous oxygen saturation

Declarations

Competing interests

The author declares that he has no competing interests.

Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.

Authors’ Affiliations

(1)
Pulmonary, Critical Care and Sleep Medicine Division, The George Washington University MFA

References

  1. Nguyen HB, Jaehne AK, Jayaprakash N, Semler MW, Hegab S, Yataco AC, Tatem G, Salem D, Moore S, Boka K, Gill JK, Gardner-Gray J, Pflaum J, Domecq JP, Hurst G, Belsky JB, Fowkes R, Elkin RB, Simpson SQ, Falk JL, Singer DJ, Rivers EP. Early goal-directed therapy in severe sepsis and septic shock: insights and comparisons to ProCESS, ProMISe, and ARISE. Crit Care. 2016;20:160.View ArticlePubMedPubMed CentralGoogle Scholar
  2. Rivers E, Nguyen B, Havstad S, Ressler J, Muzzin A, Knoblich B, et al. Early goal-directed therapy in the treatment of severe sepsis and septic shock. N Engl J Med. 2001;345(19):1368–77.View ArticlePubMedGoogle Scholar
  3. Process Investigators, Yealy DM, Kellum JA, Huang DT, Barnato AE, Weissfeld LA, et al. A randomized trial of protocol-based care for early septic shock. N Engl J Med. 2014;370(18):1683–93.View ArticleGoogle Scholar
  4. ARISE Investigators, Anzics Clinical Trials Group, Peake SL, Delaney A, Bailey M, Bellomo R, Cameron PA, et al. Goal-directed resuscitation for patients with early septic shock. N Engl J Med. 2014;371(16):1496–506.View ArticleGoogle Scholar
  5. Mouncey PR, Osborn TM, Power GS, Harrison DA, Sadique MZ, Grieve RD, et al. Trial of early, goal-directed resuscitation for septic shock. N Engl J Med. 2015;372(14):1301–11.View ArticlePubMedGoogle Scholar

Copyright

© The Author(s). 2016

Advertisement